Lecanemab (Leqembi) is not the right drug for patients with Alzheimer's disease.

Overview of attention for article published in Advances in Clinical and Experimental Medicine, September 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#5 of 665)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 4 news outlets
blogs: 1 blog

twitter: 7 X users
facebook: 2 Facebook pages

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 55 Mendeley

Summary News Blogs X Facebook Dimensions citations

So far, Dimensions has found 19 publications that cite this research output.

19

The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.

In 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more

Article in Frontiers in Aging Neuroscience (September 2024)

The 2023 yearbook of Neurorestoratology

Article in Journal of Neurorestoratology (September 2024)

Administration of Aripiprazole Alleviates Memory Impairment and Restores Damaged Glutamatergic System in 5xFAD Mice

Article in Molecular Imaging and Biology (August 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.